INS and Insulin resistance: Clinicians must be careful when interpreting higher results, especially in obese individuals or those with signs of insulin resistance, because obese, insulin-resistant patients may have normal or elevated C-peptide levels at disease recognition, even if they have autoimmune-related type 1 diabetes and they will develop complete insulin deficiency in the future (101).